TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: Immunoinflammatory platforms associated with bacterial persistence

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2548-2558

  Mattos, Katherine A ^a   Oliveira, Viviane G C ^a   D'Avila, Heloisa ^a   Rodrigues, Luciana S ^a   Pinheiro, Roberta O ^a   Sarno, Euzenir N ^a   Pessolani, Maria Cristina V ^a   Bozza, Patricia T ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; FAT DROPLET; INTERLEUKIN 10; INTERLEUKIN 12P40; NITRIC OXIDE; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 6;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; LEPROMATOUS LEPROSY; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SCHWANN CELL; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; INFLAMMATION; LEPROSY; LIPID METABOLISM; LIPIDS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MYCOBACTERIUM LEPRAE; SCHWANN CELLS; TOLL-LIKE RECEPTOR 6;

EID: 80052689787     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101344     Document Type: Article

References (55)

1. World Health Organization. 2010. Leprosy Today. Available at: http://www.who.int/lep/en/.
2. Modlin, R. L. 1994. Th1-Th2 paradigm: insights from leprosy. J. Invest. Dermatol. 102: 828-832. (Pubitemid 24210374)
3. Scollard, D. M., L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman, and D. L. Williams. 2006. The continuing challenges of leprosy. Clin. Microbiol. Rev. 19: 338-381.
4. Parkash, O. 2009. Classification of leprosy into multibacillary and paucibacillary groups: an analysis. FEMS Immunol. Med. Microbiol. 55: 1-5.
5. Virchow, R. 1863. Die krankhaften Geschwülste. August Hirschwald, Berlin.
6. Sakurai, I., and O. K. Skinsnes. 1970. Lipids in leprosy. 2. Histochemistry of lipids in human leprosy. Int. J. Lepr. Other Mycobact. Dis. 38: 389-403.
7. Mehra, V., P. J. Brennan, E. Rada, J. Convit, and B. R. Bloom. 1984. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 308: 194-196. (Pubitemid 14129561)
8. Cruz, D., A. D. Watson, C. S. Miller, D. Montoya, M. T. Ochoa, P. A. Sieling, M. A. Gutierrez, M. Navab, S. T. Reddy, J. L. Witztum, et al. 2008. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J. Clin. Invest. 118: 2917-2928.
9. Mattos, K. A., H. D'Avila, L. S. Rodrigues, V. G. Oliveira, E. N. Sarno, G. C. Atella, G. M. Pereira, P. T. Bozza, and M. C. Pessolani. 2010. Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J. Leukoc. Biol. 87: 371-384.
10. Bozza, P. T., K. G. Magalhães, and P. F. Weller. 2009. Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim. Biophys. Acta 1791: 540-551.
11. Almeida, P. E., A. R. Silva, C. M. Maya-Monteiro, D. Töröcsik, H. D'Avila, B. Dezsö, K. G. Magalhães, H. C. Castro-Faria-Neto, L. Nagy, and P. T. Bozza. 2009. Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 183: 1337-1345.
12. D'Avila, H., R. C. N. Melo, G. G. Parreira, E. Werneck-Barroso, H. C. Castro-Faria-Neto, and P. T. Bozza. 2006. Mycobacterium bovis bacillus Calmette-Guérin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 176: 3087-3097.
13. Betz, M., and B. S. Fox. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146: 108-113.
14. 2 and cyclic nucleotides. J. Immunol. 141: 2388-2393.
15. D'Avila, H., C. M. Maya-Monteiro, and P. T. Bozza. 2008. Lipid bodies in innate immune response to bacterial and parasite infections. Int. Immunopharmacol. 8: 1308-1315.
16. Lisak, R. P., D. Skundric, B. Bealmear, and S. Ragheb. 1997. The role of cytokines in Schwann cell damage, protection, and repair. J. Infect. Dis. 176 (Suppl. 2): S173-S179. (Pubitemid 27505885)
17. Rutkowski, J. L., G. F. Tuite, P. M. Lincoln, P. J. Boyer, G. I. Tennekoon, and S. L. Kunkel. 1999. Signals for proinflammatory cytokine secretion by human Schwann cells. J. Neuroimmunol. 101: 47-60. (Pubitemid 29505173)
18. Teles, R. M., S. L. Antunes, M. R. Jardim, A. L. Oliveira, J. A. Nery, A. M. Sales, E. P. Sampaio, V. Shubayev, and E. N. Sarno. 2007. Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients. J. Peripher. Nerv. Syst. 12: 195-204. (Pubitemid 47404376)
19. Cámara-Lemarroy, C. R., F. J. Guzmán-de la Garza, and N. E. Fernández-Garza. 2010. Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. Neuroimmunomodulation 17: 314-324.
20. Turka, L. A., R. E. Goodman, J. L. Rutkowski, A. A. Sima, A. Merry, R. S. Mitra, T. Wrone-Smith, G. Toews, R. M. Strieter, and B. J. Nickoloff. 1995. Interleukin 12: a potential link between nerve cells and the immune response in inflammatory disorders. Mol. Med. 1: 690-699.
21. Martini, R., S. Fischer, R. López-Vales, and S. David. 2008. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 56: 1566-1577.
22. Mattos, K. A., F. A. Lara, V. G. Oliveira, L. S. Rodrigues, H. D'Avila, R. C. Melo, P. P. Manso, E. N. Sarno, P. T. Bozza, and M. C. Pessolani. 2011. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell. Microbiol. 13: 259-273.
23. Tanigawa, K., K. Suzuki, K. Nakamura, T. Akama, A. Kawashima, H. Wu, M. Hayashi, S. Takahashi, S. Ikuyama, T. Ito, and N. Ishii. 2008. Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol. Lett. 289: 72-79.
24. Ridley, D. S. 1974. Histological classification and the immunological spectrum of leprosy. Bull. World Health Organ. 51: 451-465.
25. Singh, A. K., N. Shirasawa, K. Kyoshima, S. Kobayashi, and Y. Shimizu. 1996. Schwann cell culture from the adult animal sciatic nerve: technique and review. J. Clin. Neurosci. 3: 69-74. (Pubitemid 126658464)
26. Wade, H. W. 1962. Zenker vs formalin fixation for the histopathology of leprosy tissues and other desirable features of technique. Int. J. Lepr. 30: 477-488.
27. Marchesan, D., M. Rutberg, L. Andersson, L. Asp, T. Larsson, J. Borén, B. R. Johansson, and S. O. Olofsson. 2003. A phospholipase D-dependent process forms lipid droplets containing caveolin, adipocyte differentiation-related protein, and vimentin in a cell-free system. J. Biol. Chem. 278: 27293-27300. (Pubitemid 36876887)
28. 4-synthesizing function of macrophage lipid bodies elicited by innate immune response. J. Immunol. 179: 8500-8508.
29. Maya-Monteiro, C. M., P. E. Almeida, H. D'Avila, A. S. Martins, A. P. Rezende, H. Castro-Faria-Neto, and P. T. Bozza. 2008. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J. Biol. Chem. 283: 2203-2210.
30. Boström, P., M. Rutberg, J. Ericsson, P. Holmdahl, L. Andersson, M. A. Frohman, J. Borén, and S. O. Olofsson. 2005. Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler. Thromb. Vasc. Biol. 25: 1945-1951. (Pubitemid 41243467)
31. Lasunskaia, E. B., M. N. Campos, M. R. De Andrade, R. A. Damatta, T. L. Kipnis, M. Einicker-Lamas, and W. D. Da Silva. 2006. Mycobacteria directly induce cytoskeletal rearrangements for macrophage spreading and polarization through TLR2-dependent PI3K signaling. J. Leukoc. Biol. 80: 1480-1490. (Pubitemid 44904987)
32. D'Avila, H., N. R. Roque, R. M. Cardoso, H. C. Castro-Faria-Neto, R. C. N. Melo, and P. T. Bozza. 2008. Neutrophils recruited to the site of Mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell. Microbiol. 10: 2589-2604.
33. Zehmer, J. K., Y. Huang, G. Peng, J. Pu, R. G. Anderson, and P. Liu. 2009. A role for lipid droplets in inter-membrane lipid traffic. Proteomics 9: 914-921.
34. Oliveira, R. B., M. T. Ochoa, P. A. Sieling, T. H. Rea, A. Rambukkana, E. N. Sarno, and R. L. Modlin. 2003. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect. Immun. 71: 1427-1433. (Pubitemid 36254329)
35. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. Van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, W. A. Frazier, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11: 155-161.
36. Modlin, R. L. 2010. The innate immune response in leprosy. Curr. Opin. Immunol. 22: 48-54.
37. Bleharski, J. R., H. Li, C. Meinken, T. G. Graeber, M. T. Ochoa, M. Yamamura, A. Burdick, E. N. Sarno, M. Wagner, M. Röllinghoff, et al. 2003. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301: 1527-1530. (Pubitemid 37128543)
38. Krutzik, S. R., M. T. Ochoa, P. A. Sieling, S. Uematsu, Y. W. Ng, A. Legaspi, P. T. Liu, S. T. Cole, P. J. Godowski, Y. Maeda, et al. 2003. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 9: 525-532. (Pubitemid 36597097)
39. Sibley, L. D., and J. L. Krahenbuhl. 1987. Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon. Infect. Immun. 55: 446-450. (Pubitemid 17004126)
40. Qin, Y., C. Cheng, H. Wang, X. Shao, Y. Gao, and A. Shen. 2008. TNF-alpha as an autocrine mediator and its role in the activation of Schwann cells. Neurochem. Res. 33: 1077-1084.
41. Skoff, A. M., R. P. Lisak, B. Bealmear, and J. A. Benjamins. 1998. TNF-alpha and TGF-beta act synergistically to kill Schwann cells. J. Neurosci. Res. 53: 747-756. (Pubitemid 28423882)
42. Meyer zu Hörste, G., W. Hu, H. P. Hartung, H. C. Lehmann, and B. C. Kieseier. 2008. The immunocompetence of Schwann cells. Muscle Nerve 37: 3-13.
43. Bozza, P. T., P. Pacheco, W. Yu, and P. F. Weller. 2002. NS-398: cyclooxygenase-2 independent inhibition of leukocyte priming for lipid body formation and enhanced leukotriene generation. Prostaglandins Leukot. Essent. Fatty Acids 67: 237-244. (Pubitemid 35192168)
44. Bozza, P. T., J. L. Payne, S. G. Morham, R. Langenbach, O. Smithies, and P. F. Weller. 1996. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc. Natl. Acad. Sci. USA 93: 11091-11096. (Pubitemid 26333123)
45. 2synthesis in colon cancer cells. Cancer Res. 68: 1732-1740.
46. Samsa, M. M., J. A. Mondotte, N. G. Iglesias, I. Assunção- Miranda, G. Barbosa-Lima, A. T. Da Poian, P. T. Bozza, and A. V. Gamarnik. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5: e1000632.
47. Schmid, B., J. F. Rippmann, M. Tadayyon, and B. S. Hamilton. 2005. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem. Biophys. Res. Commun. 328: 1073-1082. (Pubitemid 40238744)
48. 2generation and increased parasite growth. J. Infect. Dis. DOI: 10.1093/infdis/JIR432.
49. Van der Pouw Kraan, T. C., L. C. Boeije, R. J. Smeenk, J. Wijdenes, and L. A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181: 775-779.
50. Alvarez, S., A. Blanco, M. Fresno, and M. A. Muñoz- Fernández. 2010. Nuclear factor-kappaB activation regulates cyclooxygenase-2 induction in human astrocytes in response to CXCL12: role in neuronal toxicity. J. Neurochem. 113: 772-783.
51. Boulant, S., P. Targett-Adams, and J. McLauchlan. 2007. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 88: 2204-2213. (Pubitemid 47194217)
52. Miyanari, Y., K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata, and K. Shimotohno. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9: 1089-1097. (Pubitemid 47338147)
53. Cáceres, N., G. Tapia, I. Ojanguren, F. Altare, O. Gil, S. Pinto, C. Vilaplana, and P. J. Cardona. 2009. Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models. Tuberculosis (Edinb.) 89: 175-182.
54. Peyron, P., J. Vaubourgeix, Y. Poquet, F. Levillain, C. Botanch, F. Bardou, M. Daffé, J. F. Emile, B. Marchou, P. J. Cardona, et al. 2008. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4: e1000204.
55. Russell, D. G., P. J. Cardona, M. J. Kim, S. Allain, and F. Altare. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10: 943-948.